Why the study?
Polio remains a global health concern with recurring outbreaks and circulating vaccine-derived poliovirus in under-immunized cohorts, motivating assessment of how vaccine allocation during outbreak responses impacts outcomes.
Does priority allocation of vaccines to under-immunized groups reduce paralytic cases and transmission in polio outbreaks?
Does priority allocation of vaccines to under-immunized groups reduce paralytic cases and transmission in polio outbreaks?
Priority allocation of polio vaccines to under-immunized groups in outbreak responses significantly reduces paralytic cases and can halt transmission if implemented quickly with high coverage.
Modeling suggests prioritizing under-immunized groups in polio outbreaks; real-world trials needed before practice change.
Polio, an infectious disease that causes paralysis, remains a global health concern, especially with the emergence of circulating vaccine-derived poliovirus (cVDPV) and recurring outbreaks in areas with cohorts of under-immunized individuals. This study assessed how the allocation of vaccines during a polio outbreak response might impact outcomes. Adapting a compartmental simulation model, we projected poliovirus transmission from 2024 to 2026 under different levels of vaccination campaign coverage (i.e., the proportion of the target population reached by vaccination), vaccine allocation schemes (e.g., across different immunity groups), and vaccination campaign delays. Results highlighted that compared to other allocation schemes, priority allocation of vaccines to under-immunized groups (i) significantly reduced the number of paralytic cases, even with lower coverage and longer delay; (ii) achieved die-out of transmission with two rounds of vaccination if the delay was short (<tex xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">≤</tex> 3 weeks) and coverage was high (<tex xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">≥</tex> 70%).
No takes yet. Share an insight, caveat, or question.
Sun et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: